The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human
- 25 September 2004
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 285 (1-2) , 135-146
- https://doi.org/10.1016/j.ijpharm.2004.08.001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Improved oral bioavailability of cyclosporin A in male Wistar rats: Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspensionInternational Journal of Pharmaceutics, 2002
- Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical EntitiesOrganic Process Research & Development, 2000
- Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral AdministrationClinical Pharmacokinetics, 1999
- Effect of Food on the Oral Bioavailability of Isosorbide‐5‐Mononitrate Administered as an Extended‐Release TabletThe Journal of Clinical Pharmacology, 1995
- Improved Oral Absorption of a Poorly Water-Soluble Drug, HO-221, by Wet-Bead Milling Producing Particles in Submicron Region.CHEMICAL & PHARMACEUTICAL BULLETIN, 1993
- Nutrient effects on intestinal drug absorptionJournal of Controlled Release, 1990
- Effects of food on drug absorptionPharmacology & Therapeutics, 1989
- Transit of pharmaceutical dosage forms through the small intestine.Gut, 1986
- Mixing-Tank Model for Predicting Dissolution Rate Control of Oral AbsorptionJournal of Pharmaceutical Sciences, 1986
- Physicochemical Model for Dose-Dependent DrugAbsorptionJournal of Pharmaceutical Sciences, 1984